Literature DB >> 18571388

Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers.

Jennifer T Sneider1, Harrison G Pope, Marisa M Silveri, Norah S Simpson, Staci A Gruber, Deborah A Yurgelun-Todd.   

Abstract

Cerebral blood volume (CBV) studies have provided important insight into the effects of illicit substances such as cannabis. The present study examined changes in regional blood volume in the frontal and temporal lobe, and the cerebellum during 28 days of supervised abstinence from cannabis. Dynamic susceptibility contrast MRI (DSCMRI) data were collected on 15 current, long-term cannabis users between 6 and 36 h after the subjects' last reported cannabis use (Day 0), and again after 7 and 28 days of abstinence. Resting state CBV images were also acquired on 17 healthy comparison subjects. The present findings demonstrate that at Day 7, cannabis users continued to display increased blood volumes in the right frontal region, the left and right temporal regions, and the cerebellum. However, after 28 days of abstinence, only the left temporal area and cerebellum showed significantly increased CBV values in cannabis users. These findings suggest that while CBV levels begin to normalize with continued abstinence from cannabis, specifically in frontal areas, other temporal and cerebellar brain regions show slower CBV decreases.

Mesh:

Substances:

Year:  2008        PMID: 18571388      PMCID: PMC2518664          DOI: 10.1016/j.euroneuro.2008.04.016

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  41 in total

1.  Neuropsychological performance in long-term cannabis users.

Authors:  H G Pope; A J Gruber; J I Hudson; M A Huestis; D Yurgelun-Todd
Journal:  Arch Gen Psychiatry       Date:  2001-10

2.  Dose-related neurocognitive effects of marijuana use.

Authors:  K I Bolla; K Brown; D Eldreth; K Tate; J L Cadet
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

3.  Effects of frequent marijuana use on memory-related regional cerebral blood flow.

Authors:  Robert I Block; Daniel S O'Leary; Richard D Hichwa; Jean C Augustinack; Laura L Boles Ponto; M M Ghoneim; Stephan Arndt; Richard R Hurtig; G Leonard Watkins; James A Hall; Peter E Nathan; Nancy C Andreasen
Journal:  Pharmacol Biochem Behav       Date:  2002-05       Impact factor: 3.533

Review 4.  Cardiovascular consequences of marijuana use.

Authors:  Stephen Sidney
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

Review 5.  Cardiovascular system effects of marijuana.

Authors:  Reese T Jones
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

6.  Perfusion imaging with NMR contrast agents.

Authors:  B R Rosen; J W Belliveau; J M Vevea; T J Brady
Journal:  Magn Reson Med       Date:  1990-05       Impact factor: 4.668

7.  Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography.

Authors:  Roy J Mathew; William H Wilson; Timothy G Turkington; Thomas C Hawk; R Edward Coleman; Timothy R DeGrado; James Provenzale
Journal:  Psychiatry Res       Date:  2002-12-30       Impact factor: 3.222

8.  Effects of smoking marijuana on brain perfusion and cognition.

Authors:  Daniel S O'Leary; Robert I Block; Julie A Koeppel; Michael Flaum; Susan K Schultz; Nancy C Andreasen; Laura Boles Ponto; G Leonard Watkins; Richard R Hurtig; Richard D Hichwa
Journal:  Neuropsychopharmacology       Date:  2002-06       Impact factor: 7.853

9.  Regional cerebral blood flow in the patients with depressive disorders.

Authors:  T Murata; R Suzuki; T Higuchi; A Oshima
Journal:  Keio J Med       Date:  2000-02

Review 10.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

View more
  22 in total

1.  BOLD responses to inhibition in cannabis-using adolescents and emerging adults after 2 weeks of monitored cannabis abstinence.

Authors:  Alexander L Wallace; Kristin E Maple; Alicia T Barr; Krista M Lisdahl
Journal:  Psychopharmacology (Berl)       Date:  2020-07-26       Impact factor: 4.530

Review 2.  The cerebellum and addiction: insights gained from neuroimaging research.

Authors:  Eric A Moulton; Igor Elman; Lino R Becerra; Rita Z Goldstein; David Borsook
Journal:  Addict Biol       Date:  2014-05       Impact factor: 4.280

3.  Functional connectivity and cannabis use in high-risk adolescents.

Authors:  Jon M Houck; Angela D Bryan; Sarah W Feldstein Ewing
Journal:  Am J Drug Alcohol Abuse       Date:  2013-11       Impact factor: 3.829

4.  Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; David Alexoff; Jean Logan; Millard Jayne; Christopher Wong; Dardo Tomasi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

Review 5.  Weighing the Evidence: A Systematic Review on Long-Term Neurocognitive Effects of Cannabis Use in Abstinent Adolescents and Adults.

Authors:  Florian Ganzer; Sonja Bröning; Stefanie Kraft; Peter-Michael Sack; Rainer Thomasius
Journal:  Neuropsychol Rev       Date:  2016-04-28       Impact factor: 7.444

6.  Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users.

Authors:  Joanna Jacobus; Diane Goldenberg; Christina E Wierenga; Neil J Tolentino; Thomas T Liu; Susan F Tapert
Journal:  Psychopharmacology (Berl)       Date:  2012-03-07       Impact factor: 4.530

7.  Examining the effects of former cannabis use on cerebellum-dependent eyeblink conditioning in humans.

Authors:  Adam B Steinmetz; Chad R Edwards; Jennifer M Vollmer; Molly A Erickson; Brian F O'Donnell; William P Hetrick; Patrick D Skosnik
Journal:  Psychopharmacology (Berl)       Date:  2011-12-02       Impact factor: 4.530

8.  Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.

Authors:  Bennis Pavisian; Bradley J MacIntosh; Greg Szilagyi; Richard W Staines; Paul O'Connor; Anthony Feinstein
Journal:  Neurology       Date:  2014-04-30       Impact factor: 9.910

Review 9.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

10.  Impact of 2 Weeks of Monitored Abstinence on Cognition in Adolescent and Young Adult Cannabis Users.

Authors:  Alexander L Wallace; Natasha E Wade; Krista M Lisdahl
Journal:  J Int Neuropsychol Soc       Date:  2020-04-20       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.